Midas Letter featured the increase in FSD Pharma (CNSX:HUGE) volume, attributing it to the overall positive run in the cannabis space. The article also stated, “All told, 53.08 million shares traded hands today—volume that was only trumped on May 29, the company’s inaugural session.” Author Benjamin Smith added FSD Pharma is worth $238 million, which places it side by side with MYM Nutraceuticals, WeedMD, Maricann Group and CannaRoyalty. Smith says, “Not many sub-quarter microcaps can make that distinction.”
Click here for the full article.
Click here to connect with FSD Pharma (CNSX:HUGE) for an Investor Presentation
The post FSD Pharma’s HUGE Run appeared first on Investing News Network.